Contineum Therapeutics (CTNM) Return on Capital Employed (2024 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Return on Capital Employed of 26.62% for Q2 2026, up 939.0% year-over-year from 2.56% in Q2 2025, and down 4.47% quarter-over-quarter from 25.48% in Q1 2026.
Contineum Therapeutics (CTNM) Return on Capital Employed (2024 - 2026) Analysis & Trends
Contineum Therapeutics' Return on Capital Employed history runs 3 years deep, the most recent figure standing at 26.62% for Q2 2026.
- In Q2 2026, Return on Capital Employed rose 939.0% year-over-year to 26.62%; the TTM figure through Jun 2026 stood at 26.62% (up 939.0% YoY), while the FY2025 annual figure was 28.96%, up 252.0% from the prior year.
- Return on Capital Employed for Q2 2026 stood at 26.62%, down from 25.48% in the prior quarter.
- The five-year high for Return on Capital Employed was 9.33% in Q1 2024, with the low at 37.67% in Q3 2025.
- The 3-year median for Return on Capital Employed is 26.05% (2026), against an average of 24.51%.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed slumped 3937 bps in 2025, then surged 939 bps in 2026.
- Contineum Therapeutics' Return on Capital Employed stood at 24.89% in 2024, then decreased by 22 bps to 30.38% in 2025, then grew by 12 bps to 26.62% in 2026.
- Business Quant data shows CTNM's Return on Capital Employed at 26.62% in Q2 2026, 25.48% in Q1 2026, and 30.38% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.76% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.74% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -55.45% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 7.88% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 26.09% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -50.93% |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | -26.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.62% |
| Mar 31, 2026 | -25.48% |
| Dec 31, 2025 | -30.38% |
| Sep 30, 2025 | -37.67% |
| Jun 30, 2025 | -36.01% |
| Mar 31, 2025 | -30.05% |
| Dec 31, 2024 | -24.89% |
| Sep 30, 2024 | -20.44% |
| Jun 30, 2024 | -22.89% |
| Mar 31, 2024 | 9.33% |